Abstract:Background Oridonin has been demonstrated to exert strong antitumor activities in various types of human cancers. Our previous study established that oridonin induced the apoptosis of and exerted an inhibitory effect on colon cancer cells in vitro and in vivo. However, the mechanisms behind the antitumor effects of oridonin on colorectal cancer are not clearly known. This study explored whether autophagy was involved in antitumorigenesis effects caused by the usage of oridonin in colon cancer and examined whether the AMPK/mTOR/ULK1 signaling pathway was involved in this process. Methods Cell viability was determined using CCK-8 assay. The distribution of cell apoptosis was evaluated using flow cytometry. RT-PCR and Western blotting analysis were conducted to identify the key target genes and proteins involved in the AMPK/mTOR cascade. AMPK siRNA was used to disturb AMPK expression. A DLD-1 cell orthotopic transplantation tumor model was established to explore the anti-cancer effects in vivo. Results Oridonin exhibited a suppressive effect on DLD-1 cells in a concentration- and time-dependent manner. Additionally, in a dose-dependent manner, oridonin induced cell apoptosis via inducing the protein expression levels of cleaved caspase-3, cleaved PARP and stimulated autophagy by increasing protein expression levels of Becin1, LC3-II, decreasing protein expression levels of LC3-I, p62, which were respectively attenuated and elevated by autophagy inhibitor 3-MA. Furthermore, oridonin upregulated the expression level of p-AMPK and downregulated the expression levels of p-mTOR, p-ULK1 in the DLD-1 cells in a dose-dependent manner. Moreover, knockdown of AMPK by a specific siRNA reversed the expression levels of proteins involved in the AMPK/mTOR pathway, autophagy and apoptosis. In addition, outcomes from the in vivo experiments also showed that oridonin treatment significantly repressed tumorigenic growth of DLD-1 cells without any side effects, which was accompanied by the upregulation of p-AMPK, LC3-II, active caspase-3 protein expression levels and the downregulation of p-mTOR and p-ULK1 protein expression levels. Conclusion This study demonstrated that oridonin induced apoptosis and autophagy of colon cancer DLD-1 cells via regulating the AMPK/mTOR/ULK1 pathway, which indicated that oridonin may be used as a novel therapeutic intervention for patients with colorectal cancer.

Preparation of nano-crystalline of oridonin and its effect on cell proliferation and apoptosis of colorectal cancer cells in vitro

Oridonin Inhibits Bxpc-3 Cell Growth Through Cell Apoptosis

Oridonin Nanosuspension Was More Effective Than Free Oridonin on G2/M Cell Cycle Arrest and Apoptosis in the Human Pancreatic Cancer PANC-1 Cell Line.

Growth Inhibition and Induction of Apoptosis in Mcf-7 Breast Cancer Cells by Oridonin Nanosuspension

Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects

Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc

Inhibitory Effect of Platycodin D on Human Colonic Cancer SW620 Cell Proliferation

Preparation of Oridonin Nanocrystals and Study of Their Endocytosis and Transcytosis Behaviours on MDCK Polarized Epithelial Cells.

In Vitro and in Vivo Antitumor Activity of Oridonin Nanosuspension

Oridonin Nanosuspension Enhances Anti-Tumor Efficacy in SMMC-7721 Cells and H22 Tumor Bearing Mice

Effects of Oridonin on Proliferation of HT29 Human Colon Carcinoma Cell Lines Both in Vitro and in Vivo in Mice.

Study on Cyclin D/Rb/p16 Signal Pathway of BxPC-3 Cell Line Treated with Oridonin

Induction of Apoptosis and G2/M Cell Cycle Arrest by Oridonin in Human Gastric Cancer BGC-823 Cells

Proteomic and functional analyses demonstrate the involvement of oxidative stress in the anticancer activities of oridonin in HepG2 cells

Induction of Apoptosis and G2/M Cell Cycle Arrest by Oridonin on Human Pancreatic Cancer PANC-1 Cells

Oridonin induces apoptosis and senescence by increasing hydrogen peroxide and glutathione depletion in colorectal cancer cells

Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells

AMPK/mTOR/ULK1 Axis-Mediated Pathway Participates in Apoptosis and Autophagy Induction by Oridonin in Colon Cancer DLD-1 Cells

Inhibitory Effect of Oridonin on Bladder Cancer T24 Cells and Its Mechanism

Study on Oridonin for Antitumor Based on Restraining Wnt Signal Pathway in Breast Cancer MCF-7 Cells

Oridonin Induces G2/M Cell Cycle Arrest and Apoptosis Via the PI3K/Akt Signaling Pathway in Hormone-Independent Prostate Cancer Cells.